Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001

Clinical Microbiology and Infection

Volumn 10, Issue 7, 2004, Pages 665-667

  Boubaker, I Boutiba Ben ^a   Ghozzi, R ^a   Abdallah, H Ben ^a   Mamlouk, K ^a   Kamoun, A ^a   Redjeb, S Ben ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Enterobacteriaceae; ESBLs; Klebsiella pneumoniae; Outbreaks; Resistance; Lactamases

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; CLAVULANIC ACID; TICARCILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; EPIDEMIC; ESCHERICHIA COLI; HOSPITAL; HUMAN; KLEBSIELLA PNEUMONIAE; NEWBORN INTENSIVE CARE; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; TUNISIA;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MIRABILIS; PROTEUS MIRABILIS;

EID: 4043123274     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00959.x     Document Type: Article

References (11)

1. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended spectrum β -lactamase phenotype and characterisation of isolates from Europe, the Americas and the Western Pacific region. Clin Microbiol Dis 2001; 32(suppl 2): S94-S103.
2. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterisation, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
3. Bush K. New β-lactamases in Gram negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001; 32: 1085-1089.
4. Coudron PE, Moland ES Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 2000; 38: 1791-1796.
5. Rhimi-Mahjoubi F, Bernier M, Arlet G et al. Identification of plasmid-encoded cephalosporinase ACC-1 among various enterobacteria (Klebsiella pneumoniae, Proteus mirabilis, Salmonella) isolated from a Tunisian hospital (Sfax 1997-2000). Pathol Biol 2002; 50: 7-11.
6. Ben Redjeb S, Ben Yaghlane H, Boujnah A, Philippon A, Labia R. Synergy between clavulanic acid and newer β lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third generation cephalosporins. J Antimicrob Chemother 1988; 21: 263-266.
7. Philippon A, Ben Redjeb S, Fournier G, Ben Hassen A. Epidemiology of extended spectrum β-lactamase. Infection 1989; 17: 347-354.
8. Verdet C, Arlet G, Ben Redjeb S, Ben Hassen A, Lagrange PH, Philippon A. Characterisation of CMY-4 an AmpC type plasmid-mediated β-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol Lett 1998; 169: 235-240.
9. Ben Hassen A, Fournier G, Kechrid A, Fendri C, Ben Redjeb S, Philippon A. Enzymatic resistance to cefotaxime in 56 strains of Klebsiella spp., Escherichia coli and Salmonella spp. at a Tunisian hospital (1984-1988). Path Biol 1990; 38: 464-469.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing, 7th edn. NCCLS document M2-A7. Wayne, PA: NCCLS, 2000.
11. Bauernfiend A, Schneider I, Jung Wirth R, Sahly H, Ullmann U. A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumoniae. Antimicrob Agents Chemother 1999; 43: 1924-1931.